Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16286461rdf:typepubmed:Citationlld:pubmed
pubmed-article:16286461lifeskim:mentionsumls-concept:C1335222lld:lifeskim
pubmed-article:16286461lifeskim:mentionsumls-concept:C1705016lld:lifeskim
pubmed-article:16286461lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:16286461lifeskim:mentionsumls-concept:C0022203lld:lifeskim
pubmed-article:16286461lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:16286461lifeskim:mentionsumls-concept:C0050156lld:lifeskim
pubmed-article:16286461pubmed:issue5lld:pubmed
pubmed-article:16286461pubmed:dateCreated2006-4-24lld:pubmed
pubmed-article:16286461pubmed:abstractTextConjugated linoleic acids (CLAs), naturally occurring fatty acids in ruminant food products, have anti-tumorigenic and pro-apoptotic properties in animal as well as in vitro models of cancer. However, the cellular mechanism has not been fully understood. NAG-1 (non-steroidal anti-inflammatory drug-activated gene-1) is induced by several dietary compounds and belongs to a TGF-beta superfamily gene associated with pro-apoptotic and anti-tumorigenic activities. The present study was performed to elucidate the molecular mechanism by which CLA stimulates anti-tumorigenic activity in human colorectal cancer (CRC) cells. The trans-10, cis-12-CLA (t10,c12-CLA) repressed cell proliferation and induced apoptosis, whereas linoleic acid or c9,t11-CLA showed no effect on cell proliferation and apoptosis. We also found that t10,c12-CLA induced the expression of a pro-apoptotic gene, NAG-1, in human CRC cells. Inhibition of NAG-1 expression by small interference RNA (siRNA) results in repression of t10,c12-CLA-induced apoptosis. Microarray analysis using t10,c12-CLA-treated HCT-116 cells revealed that activating transcription factor 3 (ATF3) was induced and its expression was confirmed by western analysis. The t10,c12-CLA treatment followed by the overexpression of ATF3 increased NAG-1 promoter activity in HCT-116 cells. We further provide the evidence that t10,c12-CLA inhibited the phosphorylation of AKT and the blockage of GSK-3 by siRNA abolished t10,c12-CLA-induced ATF3 and NAG-1 expression. The current study demonstrates that t10,c12-CLA stimulates ATF3/NAG-1 expression and subsequently induces apoptosis in an isomer specific manner. These effects may be through inhibition of AKT/GSK-3beta pathway in human CRC cells.lld:pubmed
pubmed-article:16286461pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16286461pubmed:languageenglld:pubmed
pubmed-article:16286461pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16286461pubmed:citationSubsetIMlld:pubmed
pubmed-article:16286461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16286461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16286461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16286461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16286461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16286461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16286461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16286461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16286461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16286461pubmed:statusMEDLINElld:pubmed
pubmed-article:16286461pubmed:monthMaylld:pubmed
pubmed-article:16286461pubmed:issn0143-3334lld:pubmed
pubmed-article:16286461pubmed:authorpubmed-author:SafeStephenSlld:pubmed
pubmed-article:16286461pubmed:authorpubmed-author:ElingThomas...lld:pubmed
pubmed-article:16286461pubmed:authorpubmed-author:ParkYeonhwaYlld:pubmed
pubmed-article:16286461pubmed:authorpubmed-author:BaekSeung...lld:pubmed
pubmed-article:16286461pubmed:authorpubmed-author:KimJong-SikJSlld:pubmed
pubmed-article:16286461pubmed:authorpubmed-author:LeeSeong-HoSHlld:pubmed
pubmed-article:16286461pubmed:authorpubmed-author:YamaguchiKiyo...lld:pubmed
pubmed-article:16286461pubmed:issnTypePrintlld:pubmed
pubmed-article:16286461pubmed:volume27lld:pubmed
pubmed-article:16286461pubmed:ownerNLMlld:pubmed
pubmed-article:16286461pubmed:authorsCompleteYlld:pubmed
pubmed-article:16286461pubmed:pagination972-81lld:pubmed
pubmed-article:16286461pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:meshHeadingpubmed-meshheading:16286461...lld:pubmed
pubmed-article:16286461pubmed:year2006lld:pubmed
pubmed-article:16286461pubmed:articleTitleConjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner.lld:pubmed
pubmed-article:16286461pubmed:affiliationDepartment of Pathobiology, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA.lld:pubmed
pubmed-article:16286461pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16286461pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:467entrezgene:pubmedpubmed-article:16286461lld:entrezgene
entrez-gene:9518entrezgene:pubmedpubmed-article:16286461lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16286461lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16286461lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16286461lld:pubmed